CIK 0001764013
- Large accelerated filer
Immunovant, Inc.
Sign in to watch- Ticker
- IMVT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 832771572
- Phone
- +1 917-410-3120
- Business address
- 1000 PARK FORTY PLAZA, DURHAM, NC, 27713
- Former names
- Health Sciences Acquisitions Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $895,852
- in 9 filings, $173K under 10b5-1 plans
Net −$895,852. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-25 | Macias William L. Chief Medical Officer | Sale | −509 | $16.29 | $8K | 350,151 |
| 2023-04-25 | Levine Mark S. Chief Legal Officer | Sale | −2,633 | $16.29 | $43K | 330,691 |
| 2023-04-18 | Barnett Eva Renee Chief Financial Officer | Sale | −3,423 | $15.27 | $52K | 352,588 |
| 2023-04-18 | Butchko Julia G. Chief Development Officer | Sale | −1,544 | $15.27 | $24K | 430,063 |
| 2023-04-18 | Salzmann Peter Chief Executive Officer | Sale | −3,395 | $15.27 | $52K | 1,234,369 |
| 2023-04-17 | Stout Jay S Chief Technology Officer | Grant or award | +100,000 | 100,000 | ||
| 2023-04-17 | Stout Jay S Chief Technology Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2023-04-12 | Pande Atul Director | Grant or award | +12,523 | 95,508 | ||
| 2023-04-12 | Pande Atul Director | Grant or award · Stock Option (right to buy) | +16,260 | 16,260 | ||
| 2023-04-12 | Hughes Douglas J. Director | Grant or award | +12,523 | 113,755 | ||
| 2023-04-12 | Hughes Douglas J. Director | Grant or award · Stock Option (right to buy) | +16,260 | 16,260 |
Page 18 of 18 · 351 trades